Top

Published in:

07-12-2022 | Central Nervous System Trauma

Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain Injury

Authors: Sophie Samuel, Carlton Menchaca, Aaron M. Gusdon

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2023

Highlights

Venous Thromboembolism is one of the common complications seen in hospitalized patients leading to increased mortality and morbidity.

Early initiation of anticoagulation for management of venous thromboembolism in brain injury patients is challenging due to the risk of hemorrhagic complications.

The results from this study suggest that early use of anticoagulation for venous thrombosis was not associated with poor functional outcomes.

Larger studies are warranted to assess the safety of early initiation of anticoagulation therapy in this patient population.

Cai Q, Zhang X, Chen H (2021) Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review. Thromb J 19(1):93. https://doi.org/10.1186/s12959-021-00345-zCrossRefPubMedPubMedCentral

Hawryluk GW, Furlan JC, Austin JW, Fehlings MG (2011) Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: current practice is highly variable and may be suboptimal. World Neurosurg 76(3–4):299–303. https://doi.org/10.1016/j.wneu.2011.03.034CrossRefPubMed

Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH (2014) Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med 174(8):1244–1251. https://doi.org/10.1001/jamainternmed.2014.2534CrossRefPubMedPubMedCentral

Matsushima K, Inaba K, Cho J, Mohammed H, Herr K, Leichtle S, Zada G, Demetriades D (2016) Therapeutic anticoagulation in patients with traumatic brain injury. J Surg Res 205(1):186–191. https://doi.org/10.1016/j.jss.2016.06.042CrossRefPubMed

Puckett Y, Zhang K, Blasingame J, Lorenzana J, Parameswaran S, Brooks SE, Baronia BC, Griswold J (2018) Safest time to resume oral anticoagulation in patients with traumatic brain Injury. Cureus 10(7):e2920. https://doi.org/10.7759/cureus.2920CrossRefPubMedPubMedCentral

Tykocki T, Guzek K (2016) Anticoagulation Therapy in Traumatic Brain Injury. World Neurosurg 89:497–504. https://doi.org/10.1016/j.wneu.2016.01.063CrossRefPubMed

Hawryluk GW, Austin JW, Furlan JC, Lee JB, O’Kelly C, Fehlings MG (2010) Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 8(7):1500–1508. https://doi.org/10.1111/j.1538-7836.2010.03882.xCrossRefPubMed

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ et al (2015) Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial. Trials 16:393. https://doi.org/10.1186/s13063-015-0898-4CrossRefPubMedPubMedCentral

Diringer MN, Bleck TP, Claude Hemphill J 3rd et al (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15(2):211–240. https://doi.org/10.1007/s12028-011-9605-9

10.

Carney N, Totten AM, O’Reilly C et al (2017) Guidelines for the management of severe traumatic brain Injury, Fourth Edition. Neurosurgery 80(1):6–15. https://doi.org/10.1227/NEU.0000000000001432CrossRefPubMed

11.

Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and Prevention of thrombosis, 9th ed: american college of chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226. https://doi.org/10.1378/chest.11-2296CrossRefPubMedPubMedCentral

12.

Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (6 Suppl):381S-453S. https://doi.org/10.1378/chest.08-0656

13.

Hemphill JC, Greenberg SM, Anderson CS et al (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 46(7):2032–2060. https://doi.org/10.1161/STR.0000000000000069CrossRefPubMed

14.

Steiner T, Kaste M, Forsting M et al (2006) Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The european Stroke Initiative writing Committee and the writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22(4):294–316. https://doi.org/10.1159/000094831CrossRefPubMed

15.

Nguyen NY, Frishman WH (2020) Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage. Cardiol Rev 2020;28(4):190–196. https://doi.org/10.1097/CRD.0000000000000288

16.

Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY (2015) Restarting anticoagulant treatment after Intracraniala Hemorrhage in patients with Atrial Fibrillation and the impact on recurrent stroke, mortality, and bleeding: a Nationwide Cohort Study. Circulation 132(6):517–525. https://doi.org/10.1161/CIRCULATIONAHA.115.015735CrossRefPubMed

17.

Ottosen TP, Grijota M, Hansen ML et al (2016) Use of Antithrombotic Therapy and Long-Term Clinical Outcome among Patients surviving Intracerebral Hemorrhage. Stroke 47(7):1837–1843. https://doi.org/10.1161/STROKEAHA.116.012945CrossRefPubMed

18.

Byrnes MC, Irwin E, Roach R, James M, Horst PK, Reicks P (2012) Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. World J Emerg Surg 7(1):25. https://doi.org/10.1186/1749-7922-7-25CrossRefPubMedPubMedCentral

19.

Appendix C: VTE Measurement and Tracking. Content last reviewed May 2016. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/patient-safety/resources/vtguide/appc.html

20.

The Joint Commission (2018) Specifications Manual for Joint Commission National Quality Measures – Modified Rankin Score (mRS). Accessed September 7, 2021. https://manual.jointcommission.org/releases/TJC2018A/DataElem0569.html

21.

Bailey RD, Hart RG, Benavente O, Pearce LA (2001) Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56:773–777. https://doi.org/10.1212/WNL.56.6.773

22.

Passero S, Burgalassi L, D’andrea P, Battistini N (1995) Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 26:1189–1192. https://doi.org/10.1161/01.STR.26.7.1189

23.

Cosgrove GR, Leblanc R, Meagher-Villemure K, Ethier R (1985) Cerebral amyloid angiopathy. Neurology 35:625–631. https://doi.org/10.1212/WNL.35.5.625

24.

Kearon C, Akl EA, Ornelas J, (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315–352. https://doi:https://doi.org/10.1016/j.chest.2015.11.026

25.

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921), 955–962. https://doi.org/10.1016/S0140-6736(13)62343-0

26.

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093–1100. https://doi:https://doi.org/10.1378/chest.10-0134

27.

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272. https://doi:https://doi.org/10.1378/chest.09-1584

Title: Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain Injury
Authors: Sophie Samuel
Carlton Menchaca
Aaron M. Gusdon
Publication date: 07-12-2022
Publisher: Springer US
Keywords: Central Nervous System Trauma
Direct Oral Anticoagulant
Phlebothrombosis
Warfarin
Direct Oral Anticoagulant
Published in: Journal of Thrombosis and Thrombolysis / Issue 2/2023
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-022-02745-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Highlights

Please log in to get access to this content

Other articles of this Issue 2/2023

Impact of dabigatran dose on drug levels in asian patients with atrial fibrillation or venous thromboembolism: evidence from pharmacological to clinical outcomes

Could PD-L1 positivity be associated with venous thrombosis in patients with non-small cell lung cancer?

Increased incidence of venous thromboembolism associated with inferior vena cava filter placement in patients diagnosed with isolated calf deep vein thrombosis after intracranial hemorrhage or intracranial operation

Clinical impact of oral anticoagulation among octogenarians with atrial fibrillation and anaemia

Angiojet pharmacomechanical thrombectomy versus anticoagulant therapy alone in massive cancer-associated thrombosis: a single centre retrospective cohort study

Management of venous thromboembolism in morbidly obese patients: a 10-year review

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials